Publications
Matthew J. Wieduwilt, Scott Thomas, Rebecca L. Olin, Aaron C. Logan, Lloyd E. Damon, Thomas G. Martin, McNancy Kang, Peter H. Sayre, Wanda Boyer, Karin ML Gaensler, Kirsten Anderson, Pamela Munster, Charalambos Andreadis. Panobinostat-Augmented Cytarabine and Daunorubicin (7+3) Induction for Older Patients with AML or High-Risk MDS Is Well Tolerated and Results in Favorable Clinical Outcomes: The Panda Trial. Blood. 2015. PMID:
Gabriel N. Mannis, Thomas G. Martin, Lloyd E. Damon, Charalambos Andreadis, Rebecca L. Olin, Katie Kong, Malek Faham, Weiyun Z. Ai, Karin ML Gaensler, Peter H. Sayre, Jeffrey L. Wolf, Aaron C. Logan. Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk Following Autologous Hematopoietic Cell Transplantation. Blood. 2015. PMID:
Volonaki E, Mutalib M, Kiparissi F, Shah N, Lindley KJ, Elawad M. Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis. European journal of gastroenterology & hepatology. 2015. PMID: 26426835
Crawford ED, Petrylak DP, Higano CS, Kibel AS, Kantoff PW, Small EJ, Shore ND, Ferrari A. Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer. The Canadian journal of urology. 2015. PMID: 26688132
Tempero M. Paying Less for High-Value Care--Are You Kidding Me? Journal of the National Comprehensive Cancer Network : JNCCN. 2015. PMID: 26656513
Amin DN, Ruiz-Saenz A, Gulizia N, Moasser MM. Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib. Oncotarget. 2015. PMID: 26516700
Rodriguez-Wallberg K, Turan V, Munster P, Oktay K. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients? Annals of oncology : official journal of the European Society for Medical Oncology. 2015. PMID: 26609009
Bluestone JA, Buckner JH, Fitch M, Gitelman SE, Gupta S, Hellerstein MK, Herold KC, Lares A, Lee MR, Li K, Liu W, Long SA, Masiello LM, Nguyen V, Putnam AL, Rieck M, Sayre PH, Tang Q. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Volume 7 of Issue 315 Science translational medicine. 2015. PMID: 26606968
Munster P, Aggarwal R, Hong D, Schellens JH, van der Noll R, Specht J, Witteveen PO, Werner TL, Dees EC, Bergsland E, Agarwal N, Kleha JF, Durante M, Adams L, Smith DA, Lampkin TA, Morris SR, Kurzrock R. First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015. PMID: 26603258
Garrett GL, He SY, Sabouni N, Daud A, Arron ST. Combined dabrafenib and trametinib therapy in metastatic melanoma and organ transplantation: Case report and review of the literature. JAAD case reports. 2015. PMID: 27051803
Esposito MT, Zhao L, Fung TK, Rane JK, Wilson A, Martin N, Gil J, Leung AY, Ashworth A, So CW. Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors. Nature medicine. 2015. PMID: 26594843
Vijayaraghavan M, Hurst S, Pierce JP. A Qualitative Examination of Smoke-Free Policies and Electronic Cigarettes Among Sheltered Homeless Adults. American journal of health promotion : AJHP. 2015. PMID: 26559719
Li B, Luo X, Deng B, Wang J, McComb DW, Shi Y, Gaensler KM, Tan X, Dunn AL, Kerlin BA, Dong Y. An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo. Nano letters. 2015. PMID: 26529392
Bol GM, Xie M, Raman V. DDX3, a potential target for cancer treatment. Volume 14 Molecular cancer. 2015. PMID: 26541825
Sanlorenzo M, Vujic I, Daud A, Algazi A, Gubens M, Luna SA, Lin K, Quaglino P, Rappersberger K, Ortiz-Urda S. Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression. JAMA dermatology. 2015. PMID: 26222619
Mabray MC, Cohen BA, Villanueva-Meyer JE, Valles FE, Barajas RF, Rubenstein JL, Cha S. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms. AJR. American journal of roentgenology. 2015. PMID: 26496556
Tempero M. At Last: Getting Paid to Think! Journal of the National Comprehensive Cancer Network : JNCCN. 2015. PMID: 26553759
Kurzrock R, Colevas AD, Olszanski A, Akerley W, Arteaga CL, Carson WE, Clark JW, DiPersio JF, Ettinger DS, Morgan RJ, Schwartzberg LS, Venook AP, Gocke CD, Tait J, Stewart FM. NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys. Journal of the National Comprehensive Cancer Network : JNCCN. 2015. PMID: 26553764
Moasser MM, Krop IE. The Evolving Landscape of HER2 Targeting in Breast Cancer. JAMA oncology. 2015. PMID: 26204261
Sheikhbahaei S, Ahn SJ, Moriarty E, Kang H, Fakhry C, Subramaniam RM. Intratherapy or Posttherapy FDG PET or FDG PET/CT for Patients With Head and Neck Cancer: A Systematic Review and Meta-analysis of Prognostic Studies. AJR. American journal of roentgenology. 2015. PMID: 26496559